Karyopharm Therapeutics (kpti 3 10/15/25)
13F holders, Q4 2024 (December 31)1holders
0new positions
0sold out
$0.78avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Karyopharm Therapeutics (kpti 3 10/15/25) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was Exome Asset Management LLC ($1.6M).
- Company
- Karyopharm Therapeutics (kpti 3 10/15/25)
- CUSIP
- 48576UAA4
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Exome Asset Management LLC | 1.17% | No change | 2,000,000 | $1.6M |
"% of holder's portfolio" is KARYOPHARM THERAPEUTICS (KPTI 3 10/15/25)'s weight in each manager's 13F, not the share of Karyopharm Therapeutics (kpti 3 10/15/25) the manager owns.